MATH - MATH

Option chain shows key data for Metalpha Technology's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Metalpha Technology.

Metalpha Technology (NASDAQ:MATH) Stock, Option Chain

Metalpha Technology

Metalpha Technology Holding Ltd is a digital asset focused wealth management company. The company predominantly generates revenue from the execution of cryptocurrency-related transactions, which includes the issuance of derivative products to over-the-counter (OTC) clients and its proprietary trading activities. It has partnered with a crypto exchange to provide crypto derivative market-making services for its clients, facilitating the trading of crypto derivative products. In addition, the company also engages in providing traditional financial derivative products, and asset management services. It operates in a single segment which is the trading of proprietary digital assets and derivative contracts, and derives a majority of its revenue from Hong Kong.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ALPP

ARAV

BDRX

BDTX

CRVS

FEMY

FOXO

FUBO

GRPN

GRRR

HELE

IOVA

JUPW

LYFT

MATH

MRKR

MyMD Pharmaceuticals, Inc. - Common Stock

MYMD

NBTX

NCRA

NEON

NMTC

NSTG

NVAX

PRST

Market Index Target Term Securities Linked To The Dow Jones Industrial Average

SDIG

SFWL

SISI

SYTA

TIVC

TPHS

TTCF

TTOO

VOXX

XELB

XXII

Gainers


	Mobilicom Limited  (NASDAQ: MOB) shares jumped 81.3% to $2.7187 after the company announced it received a commercial scale purchase order from Teledyne-FLIR for the production of drones for the U.S. Department of Defense.


Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Short Ideas

Pre-Market Outlook

COIN

FRGE

ITIC

The most overbought stocks in the financial sector presents an opportunity to go short on these overvalued companies.

Top 5 Financial Stocks That Are Ticking Portfolio Bombs

AKAN

ALRN

AMAM

APLS

ARBE

ATLX

BBIG

BCRX

Chemomab Therapeutics Ltd. - American Depositary Shares

CMMB

CVRX

DFIN

EFTR

ELAN

FSLY

HCDI

LANV

LNZA

MHUA

NEXI

OKYO

OWLT

PLAB

RETA

SGML

SNAL

SPRC

SRNE

THCH

TMDI

TRKA

TVTX

UFAB

ZDGE

Gainers


	Arbe Robotics Ltd.  (NASDAQ: ARBE) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.


Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday&#39;s Mid-Day Session

Metalpha Technology Holding Limited - Ordinary Shares

Metalpha Technology Holding Ltd

MathChain - United States Dollar

Management

Reported Thursday, Metalpha Technology Appoints Pengyuan Fan As Chief Financial Officer, Effective November 28

Metalpha Says It Regained Compliance With Nasdaq's Periodic Filing Requirement

Metalpha Technology Holding Limited (NASDAQ:<a href="https://www.benzinga.com/stock/MATH#NASDAQ">MATH</a>) (the "Company" or "Metalpha"), a global digital asset-focused wealth management company, today announced it, through its subsidiary, has adopted the Antalpha BTC Mining Index for its BTC mining stocks fund. The index was recently launched by Antalpha and FTSE Russell.
Metalpha's Bitcoin mining stock fund is managed by a wholly-owned subsidiary of the Company, LSQ Capital Limited. The fund uses the Antalpha BTC Mining Index as the benchmark to invest in publicly listed Bitcoin mining companies.
Antalpha is the world's leading Bitcoin ecosystem service provider for institutional partners. As a strategic partner of Bitmain, Antalpha is trusted by institutions, startups, and qualified investors to drive innovation in blockchain technology and applications. It has become a leading company in the global blockchain financial services ecosystem.
The Antalpha BTC Mining Index selects the top ten publicly traded US Bitcoin mining companies and tracks their respective performance. The Antalpha BTC Mining Index will offer mainstream financial investors a reliable channel to gain crypto exposure. The index will be rebalanced every six months to reflect the market conditions.
Metalpha is one of the largest crypto derivatives traders in Asia and is dedicated to providing tailor made wealth management and hedging solutions to financial institutions including family offices, investment funds, crypto mining companies, etc. Metalpha previously launched a fund to invest in GBTC, which has seen large gains since launch, with its net asset value increased to 269.84%, outperforming Bitcoin by about 39% from $27,265 to $62,867.

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

Reported Earlier, Metalpha Technology Adopts Antalpha BTC Mining Index for New Bitcoin Mining Fund

WIIM

FNWD

HOOD

HWBK

KSPI

UPST

VBFC

WENA

Shares of companies within the broader financial sector are trading lower amid overall market sentiment as investors evaluate NVIDIA ahead of its earnings report and SMCI Form 10-K delay.

Earnings

Metalpha Technology Fiscal 2023 EPS $(0.44) Vs. $(0.62) YoY; Income From Wealth Management Business $5.69M Vs. $0.12M YoY

Metalpha Technology Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MATH#NASDAQ">MATH</a>) (the &quot;Company&quot; or &quot;Metalpha&quot;), a global digital asset-based wealth management company, today announced that on&nbsp;August 17, 2023&nbsp;it has received a written notice from The Nasdaq Stock Market LLC (the &quot;Nasdaq&quot;) which states that, as a result of not having timely filed its annual report on Form 20-F for the fiscal year ended&nbsp;March 31, 2023&nbsp;(the &quot;2023 Form 20-F&quot;), Metalpha is not in compliance with Nasdaq Listing Rule 5250(c)(1), which requires timely filing of periodic reports with the Securities and Exchange Commission (the &quot;SEC&quot;). This notice has no immediate effect on the listing or trading of Metalpha&#39;s ordinary shares on the Nasdaq Capital Market.

Metalpha Receives Notification of Deficiency from Nasdaq, Relating to Delayed Filing of Annual Report

<h3>Gainers</h3>
<ul>
<li>Mobilicom Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mob#NASDAQ">MOB</a>) shares jumped 81.3% to $2.7187 after the company announced it received a commercial scale purchase order from Teledyne-FLIR for the production of drones for the U.S. Department of Defense.</li>
<li>Nanobiotix S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nbtx#NASDAQ">NBTX</a>) shares jumped 45.5% to $7.32 after the company entered into a license agreement with Janssen Pharmaceutical for global co-development and commercialization of NBTXR3.</li>
<li>T2 Biosystems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttoo#NASDAQ">TTOO</a>) shares rose 36% to $0.1565 after gaining over 38% on Friday.</li>
<li>Jupiter Wellness, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jupw#NASDAQ">JUPW</a>) gained 34.8% to $0.4934 after the company announced it has executed an Asset Purchase Agreement with GBB Drink Lab to acquire all operating assets including the &quot;Safety Shot&quot; rapid alcohol detox drink.</li>
<li>NanoString Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nstg#NASDAQ">NSTG</a>) shares gained 32.4% to $4.90 after the company said it expects second-quarter revenue to be over $44 million, above the upper end of its guidance range and the $41 million consensus estimate. The company also reiterated FY23 revenue guidance above the consensus estimate.</li>
<li>Gorilla Technology Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grrr#NASDAQ">GRRR</a>) gained 30.8% to $6.15. Gorilla Technology shares jumped 125% on Friday after the company signed a $270 million contract with the Government of Egypt to implement a Smart Government Security Convergence solution.</li>
<li>Shineco, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sisi#NASDAQ">SISI</a>) gained 28.5% to $0.4165 after the company announced its subsidiary received marketing and distribution approval for its Cardiac 5-Minute Test from the Jiangsu Bureau of China&#39;s National Medical Products Administration.</li>
<li>Alpine 4 Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alpp#NASDAQ">ALPP</a>) shares rose 22% to $2.05 after the company said its subsidiary, Vayu Aerospace Corporation, received its first $5.25m purchase order from its $100 million supply agreement with U.S. Government contractor, All American Contracting, Inc.</li>
<li>Novavax, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nvax#NASDAQ">NVAX</a>) gained 21.2% to $8.77. The European Commission recently approved Novavax&rsquo;s Nuvaxovid (NVX-CoV2373), following a positive opinion for a full authorization from the Committee for Medicinal Products for Human Use of the European Medicines Agency.</li>
<li>Marker Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrkr#NASDAQ">MRKR</a>) rose 19.8% to $5.20 after the company announced the European Medicines Agency granted MT-401 an Orphan Drug Designation.</li>
<li>NeuroOne Medical Technologies Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmtc#NASDAQ">NMTC</a>) gained 19% to $1.44.</li>
<li>Icahn Enterprises L.P. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iep#NASDAQ">IEP</a>) gained 17.8% to $34.02 after Carl Icahn amended loan agreements, disconnecting his personal loans from the share price, increasing his collateral and establishing a plan to repay the loans within three years. This was an issue raised in Hindenburg Research&#39;s short report on the stock issued in May.</li>
<li>Iovance Biotherapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iova#NASDAQ">IOVA</a>) gained 17.5% to $8.51 after the company announced regulatory, clinical updates for TIL therapy in advanced non-small cell lung cancer.</li>
<li>SOS Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sos#NYSE">SOS</a>) gained 17.4% to $5.31.</li>
<li>Aravive, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arav#NASDAQ">ARAV</a>) climbed 17.4% to $1.55. Cantor Fitzgerald reiterated Aravive with an Overweight and maintained $18 price target.</li>
<li>Advent Technologies Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/adn#NASDAQ">ADN</a>) gained 17.4% to $0.7399.</li>
<li>Corvus Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/crvs#NASDAQ">CRVS</a>) jumped 17% to $3.03.</li>
<li>Stronghold Digital Mining, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sdig#NASDAQ">SDIG</a>) gained 16.1% to $8.16.</li>
<li>Helen of Troy Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hele#NASDAQ">HELE</a>) rose 15.7% to $130.26 after the company reported better-than-expected first-quarter financial results and issued guidance.</li>
<li>TMC the metals company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmc#NASDAQ">TMC</a>) jumped 15.3% to $2.9150 after ThinkEquity initiated coverage on the stock with a Buy rating and announced a $6 price target.</li>
<li>fuboTV Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fubo#NYSE">FUBO</a>) gained 14.2% to $2.48.</li>
<li>Groupon, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grpn#NASDAQ">GRPN</a>) jumped 13.8% to $6.95.</li>
<li>Siyata Mobile Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/syta#NASDAQ">SYTA</a>) shares climbed 12.9% to $0.07 after gaining around 12% on Friday.</li>
<li>Lyft, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyft#NASDAQ">LYFT</a>) rose 11.2% to $11.26.</li>
<li>Black Diamond Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bdtx#NASDAQ">BDTX</a>) shares gained 7.6% to $4.7450. Black Diamond Therapeutics Director Rajeev Shah purchased 935,850 shares at an average price of $5.00 per share.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Tivic Health Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tivc#NASDAQ">TIVC</a>) shares fell 41.4% to $0.0650 after the company priced public offering of 32.5 million shares at $0.055 per share.</li>
<li>Neonode Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/neon#NASDAQ">NEON</a>) fell 33.8% to $4.85 after dropping over 8% on Friday.</li>
<li>ProMIS Neurosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pmn#NASDAQ">PMN</a>) shares dropped 19.7% to $2.81. The company announced plans to voluntarily delist from the Toronto Stock Exchange.</li>
<li>Xcel Brands, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xelb#NASDAQ">XELB</a>) dipped 19.4% to $1.16.</li>
<li>Nocera, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ncra#NASDAQ">NCRA</a>) dropped 18.4% to $1.6480.</li>
<li>Presto Automation Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/prst#NASDAQ">PRST</a>) fell 18.1% to $3.49. Rajat Suri, 10% owner at Presto Automation, reported a large insider sell on July 6.</li>
<li>Tattooed Chef, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ttcf#NASDAQ">TTCF</a>) fell 16.4% to $0.2175.</li>
<li>Trinity Place Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tphs#NYSE">TPHS</a>) dropped 14.4% to $0.5481.</li>
<li>The Aaron&#39;s Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/aan#NYSE">AAN</a>) fell 12.2% to $13.41 after Loop Capital downgraded the stock from Buy to Hold.</li>
<li>FOXO Technologies Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/foxo#NYSE">FOXO</a>) dropped 12.2% to $0.18.</li>
<li>Metalpha Technology Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/math#NASDAQ">MATH</a>) declined 11.8% to $1.27.</li>
<li>Shengfeng Development Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sfwl#NASDAQ">SFWL</a>) fell 11.3% to $8.97.</li>
<li>FMC Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fmc#NYSE">FMC</a>) dropped 11.3% to $92.42 after the company issued weak revenue guidance.</li>
<li>Biodexa Pharmaceuticals Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bdrx#NASDAQ">BDRX</a>) fell 10.5% to $3.8899. Biodexa Ltd, subsidiary of Biodexa Pharmaceuticals, has completed the enrolment and treatment of nine pediatric patients in the ongoing Phase 1 study of MTX-110 in newly diagnosed diffuse midline gliomas.</li>
<li>SunCar Technology Group Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sda#NASDAQ">SDA</a>) dropped 9.8% to $20.05.</li>
<li>MyMD Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mymd#NASDAQ">MYMD</a>) declined 9.7% to $1.0470.</li>
<li>VOXX International Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/voxx#NASDAQ">VOXX</a>) fell 8.8% to $11.53.</li>
<li>22nd Century Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xxii#NASDAQ">XXII</a>) fell 8.5% to $2.45.</li>
<li>Femasys Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/femy#NASDAQ">FEMY</a>) fell 7% to $0.4785.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/news/23/07/33163474/this-analyst-with-83-accuracy-rate-sees-around-7-upside-in-alphabet-here-are-5-stock-picks-for-last"> This Analyst With 83% Accuracy Rate Sees Around 7% Upside In Alphabet - Here Are 5 Stock Picks For Last Week From Wall Street&#39;s Most Accurate Analysts</a>

Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session

The most overbought stocks in the financial sector presents an opportunity to go short on these overvalued companies.
The RSI is a momentum indicator, which compares a stock&#39;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#39;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the <a href="https://www.benzinga.com/topic/rsi"> RSI is above 70.</a>
Here&rsquo;s the latest list of major overbought players in this sector.
<h3>Forge Global Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/frge#NYSE">FRGE</a>)</h3>
<ul>
<li>Forge Global Holdings said it has been added as a member of the U.S. Small-Cap Russell 2000&reg; Index. The company&rsquo;s stock has a <a href="https://www.benzinga.com/quote/FRGE">52-week high of $9.40. </a>.</li>
<li>RSI Value: 73.42</li>
<li>FRGE Price Action: Shares of Forge Global rose 2.1% to close at $2.50 on Thursday.</li>
</ul>
<h3>Metalpha Technology Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/math#NASDAQ">MATH</a>)</h3>
<ul>
<li>Metalpha, during April, said it has regained compliance with Nasdaq&#39;s minimum bid price requirement. The company&rsquo;s <a href="https://www.benzinga.com/quote/MATH"> stock has a 52-week high </a> of $1.42.</li>
<li>RSI Value: 80.19</li>
<li>MATH Price Action: Shares of Metalpha Technology gained 7.6% to close at $1.41 on Thursday.</li>
</ul>
<h3>Investors Title Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/itic#NASDAQ">ITIC</a>)</h3>
<ul>
<li>Investors Title Company reported first-quarter net income of $1.2 million, or 62 cents per diluted share. Chairman J. Allen Fine commented, &ldquo;The title insurance industry continued to experience economic headwinds in the first quarter. While mortgage rates declined slightly from the prior quarter, the overall higher level continued to negatively impact home sales and commercial real estate activity.&rdquo; The company has a <a href="https://www.benzinga.com/quote/ITIC"> 52-week high </a> of $168.98.</li>
<li>RSI Value: 73.28</li>
<li>ITIC Price Action: Shares of Investors Title Company rose 1.7% to close at $150.01 on Thursday.</li>
</ul>
<h3>Hywin Holdings Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hyw#NASDAQ">HYW</a>)</h3>
<ul>
<li>Hywin Holding reported a decline in H1 EPS. Ms. Wang Dian, Chief Executive Officer and Director of Hywin, commented, &ldquo;We are encouraged by Hywin Wealth&rsquo;s solid performance and strong financial and operational results in the first half of fiscal year 2023, which demonstrated its resilience in the face of macro uncertainties and softening capital markets, as well as COVID-19-related challenges in China through the end of 2022.&rdquo; The company&rsquo;s 52-week high is $7.80.</li>
<li>RSI Value: 73.97</li>
<li>HYW Price Action: Shares of Hywin Holdings rose 1% to close at $7.18 on Thursday.</li>
</ul>
<h3>Coinbase Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/coin#NASDAQ">COIN</a>)</h3>
<ul>
<li>Piper Sandler downgraded the stock from Overweight to Neutral and lowered its price target from $65 to $60. The company <a href="https://www.benzinga.com/quote/COIN"> has a 52-week high </a> of $116.30.</li>
<li>RSI Value: 72.14</li>
<li>COIN Price Action: Shares of Coinbase fell 0.3% to settle at $78.10 on Thursday.</li>
</ul>
&nbsp;
Read More: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/07/33132019/40m-bet-on-moonlake-immunotherapeutics-check-out-these-3-stocks-insiders-are-buying"> $40M Bet On MoonLake Immunotherapeutics? Check Out These 3 Stocks Insiders Are Buying </a>

<h3>Gainers</h3>
<ul>
<li>Marpai (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRAI#NASDAQ">MRAI</a>) shares increased by 16.7% to $1.0 during Thursday's pre-market session. The market value of their outstanding shares is at $21.4 million. </li>
<li>Dunxin Financial Hldgs (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/DXF#AMEX">DXF</a>) shares rose 8.71% to $0.11. The market value of their outstanding shares is at $2.3 million. </li>
<li>USCB Financial Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USCB#NASDAQ">USCB</a>) stock increased by 6.1% to $10.25. The company's market cap stands at $201.1 million. </li>
<li>Lion Group Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LGHL#NASDAQ">LGHL</a>) shares increased by 5.49% to $0.24. The market value of their outstanding shares is at $13.2 million. </li>
<li>MoneyLion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ML#NYSE">ML</a>) shares increased by 5.23% to $0.47. The company's market cap stands at $123.7 million. </li>
<li>Metalpha Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MATH#NASDAQ">MATH</a>) shares moved upwards by 5.0% to $1.0. The company's market cap stands at $30.9 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Heritage Insurance Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HRTG#NYSE">HRTG</a>) stock decreased by 33.6% to $1.98 during Thursday's pre-market session. The company's market cap stands at $50.6 million. </li>
<li>AMTD IDEA Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMTD#NYSE">AMTD</a>) stock fell 4.22% to $1.59. The market value of their outstanding shares is at $300.1 million. </li>
<li>Progressive (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PGR#NYSE">PGR</a>) shares declined by 4.21% to $141.91. The market value of their outstanding shares is at $83.0 billion. </li>
<li>PennyMac Mortgage (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PMT#NYSE">PMT</a>) shares declined by 3.23% to $12.0. The company's market cap stands at $1.0 billion. 
See Also: <a href="http://www.benzinga.com/money/best-financial-services-stocks/" title="www.benzinga.com/money/best-financial-services-stocks/">www.benzinga.com/money/best-financial-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMTD

HRTG

LGHL

MRAI

USCB

10 Financials Stocks Moving In Thursday's Pre-Market Session

Metalpha Technology Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MATH#NASDAQ">MATH</a>) (the &quot;Company&quot; or &quot;Metalpha&quot;), a global&nbsp;crypto-based wealth management company, announced that on&nbsp;March 31, 2023&nbsp;it received a written notice from The Nasdaq Stock Market LLC (the &quot;Nasdaq&quot;) which states the Company has regained compliance with the minimum bid price requirement set forth under the Nasdaq Listing Rule 5550(a)(2) (the &quot;Minimum Bid Price Requirement&quot;) and currently meets all other applicable criteria for continued listing.
As previously announced, the Company received a written notification on&nbsp;September 21, 2022&nbsp;from the Nasdaq Listing Qualifications Department that the Company was not in compliance with the Minimum Bid Price Requirement as the closing bid price of the Company&#39;s ordinary shares, par value&nbsp;US$0.0001&nbsp;per share (the &quot;Ordinary Shares&quot;), was below&nbsp;$1.00&nbsp;per share for a period of 30 consecutive business days.
In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company was provided 180 calendar days, or until March 20, 2023, to regain compliance with the Minimum Bid Price Requirement. To regain compliance, the Company&#39;s Ordinary Shares must have a closing bid price of at least&nbsp;$1.00&nbsp;per share for a minimum of 10 consecutive business days.
Per the notice the Company received from Nasdaq on&nbsp;March 31, 2023, the Company regained compliance with the Minimum Bid Price Requirement when the closing bid price of the Company&#39;s Ordinary Shares maintained&nbsp;$1.00&nbsp;per share or greater for 19 consecutive business days and the matter is now closed.

Reported Late Monday April 3, Metalpha Has Regained Compliance With Nasdaq's Minimum Bid Price Requirement

Metalpha Technology Holding Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MATH#NASDAQ">MATH</a>) (the &quot;Company&quot; or &quot;Metalpha&quot;), a digital assets service provider, today announced its preliminary unaudited financial results for the six-month period ended&nbsp;September 30, 2022&nbsp;(the&nbsp;&quot;1H 2023&quot;).
In 1H 2023, the Company&#39;s revenue from fair value change of proprietary trading digital assets (Trading Revenue）grew by more than&nbsp;3,000%&nbsp;against the six-month period ended&nbsp;March 31, 2022&nbsp;(&quot;2H 2022&quot;), rising from just over&nbsp;$122,000&nbsp;in 2H 2022 to approximately&nbsp;$3.9 million&nbsp;in 1H 2023. The Company has also seen substantial growth of over&nbsp;300%&nbsp;in its aggregate notional amount of derivative products issuance from about&nbsp;$48.9 million&nbsp;in 2H 2022 to about&nbsp;$198 million&nbsp;in 1H 2023, showing robust demand from Metalpha&#39;s global customer base, which includes&nbsp;crypto&nbsp;and blockchain mining companies, institutional investors and family offices. Trading revenue and derivative product issuance are key metrics Metalpha analyzes in evaluating its business scale and success.

Reported Late Thursday March 2, Metalpha Reports Preliminary First Half Period Ended September 30,2022 (1H 2023) Unaudited Results; Revenue Of $3.9M

Buybacks

Metalpha Technology Plans Repurchase Of Up To $5M Of Its Shares Over Next 12 Months

Metalpha Technology Enters Partnership With Litecoin Foundation To Develop Hedging Solutions For Sustainable Crypto Mining

ARES

CMTG

CRBG

DBRG

Hannon Armstrong Sustainable Infrastructure Capital

HASI

MSCI

NDAQ

PNFP

SBNY

TROW

TRUP

Shares of several companies in the broader financial services sector are trading lower for the session as higher rates dampen market sentiment and as investors digest recent earnings reports.

<h3>Gainers</h3>
<ul>
<li>Arbe Robotics Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/arbe#NASDAQ">ARBE</a>) gained 62.8% to $7.08. Arbe Robotics is expected to report its financial results for the fourth quarter on Thursday, March 2, 2023.</li>
<li>Ambrx Biopharma Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amam#NYSE">AMAM</a>) surged 59% to $5.17. Ambrx Biopharma recently announced initial data from its ongoing Phase 1 APEX-01 trial of ARX517, Ambrx&#39;s proprietary anti-PSMA ADC, in prostate cancer patients.</li>
<li>Harbor Custom Development, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcdi#NASDAQ">HCDI</a>) shares jumped 50.3% to $0.5260 after the company said it has contracted to sell mills Crossing townhomes for $14.25 million.</li>
<li>Mobilicom Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mob#NASDAQ">MOB</a>) shares gained 37.4% to $2.1307 after the company announced it has entered a strategic partnership with Mistral, a prime contractor for the US Department of Defense.</li>
<li>Sorrento Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/srne#NASDAQ">SRNE</a>) jumped 33% to $0.4151.</li>
<li>LanzaTech Global, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lnza#NASDAQ">LNZA</a>) gained 27.7% to $5.30.</li>
<li>Atlas Lithium Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atlx#NASDAQ">ATLX</a>) rose 25.4% to $9.05.</li>
<li>Chemomab Therapeutics Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cmmb#NASDAQ">CMMB</a>) jumped 25% to $2.45 after the company announced FDA clearance of its Investigational New Drug Application to evaluate CM-101 in a Phase 2 trial in adults with systemic sclerosis.</li>
<li>Zedge, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/zdge#NYSE">ZDGE</a>) rose 21.1% to $3.27. Zedge, during December, posted a Q1 loss of $0.01 per share.</li>
<li>Troika Media Group Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/trka#NASDAQ">TRKA</a>) shares rose 20.6% to $0.2655 after dropping 4% on Friday.</li>
<li>Helix Energy Solutions Group, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hlx#NYSE">HLX</a>) surged 17.7% to $8.98 after the company posted a profit for the fourth quarter.</li>
<li>Titan Medical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmdi#NASDAQ">TMDI</a>) gained 16% to $0.2212.</li>
<li>Siyata Mobile Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/syta#NASDAQ">SYTA</a>) rose 14% to $0.1733. Siyata received $750,000 order for its next generation push-to-talk over cellular solution.</li>
<li>Travere Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tvtx#NASDAQ">TVTX</a>) jumped 13.6% to $20.24. The FDA granted accelerated approval to Travere Therapeutics&rsquo; Filspari (sparsentan) to reduce proteinuria in adults with primary IgAN at risk of rapid disease progression.</li>
<li>Sigma Lithium Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sgml#NASDAQ">SGML</a>) gained 13.1% to $33.34 following reports that Tesla is considering a bid for the battery metals mining company.</li>
<li>Dingdong (Cayman) Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ddl#NYSE">DDL</a>) gained 12.2% to $5.07.</li>
<li>The Manitowoc Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/mtw#NYSE">MTW</a>) jumped 11.8% to $16.06 after reporting Q4 results.</li>
<li>Apellis Pharmaceuticals Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/apls#NASDAQ">APLS</a>) shares rose 11.4% to $61.96 after the company said that the FDA approved SYFOVRE as first and only treatment for geographic atrophy.</li>
<li>Meihua International Medical Technologies Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mhua#NASDAQ">MHUA</a>) gained 10.2% to $28.67.</li>
<li>Vir Biotechnology, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vir#NASDAQ">VIR</a>) gained 9.8% to $28.27 after Goldman Sachs upgraded the stock from Neutral to Buy and raised its price target from $41 to $53.</li>
<li>Owlet Inc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/owlt#NYSE">OWLT</a>) rose 8.9% to $0.3711 after reporting a $30 million private placement financing.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Aileron Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/alrn#NASDAQ">ALRN</a>) shares fell 43.5% to $1.3450 after the company announced termination of Phase 1b breast cancer chemoprotection trial and exploration of strategic alternatives.</li>
<li>CVRx, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cvrx#NASDAQ">CVRX</a>) fell 42.6% to $9.87 after the company reported preliminary results of the BeAT-HF post-market randomized clinical trial.</li>
<li>OKYO Pharma Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/okyo#NASDAQ">OKYO</a>) fell 26.5% to $2.7501 after surging 58% on Friday. OKYO Pharma, during December, announced U.S. FDA clearance of IND application for OK-101 for the treatment of dry eye disease.</li>
<li>Akanda Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akan#NASDAQ">AKAN</a>) fell 21% to $0.2350.</li>
<li>Metalpha Technology Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/math#NASDAQ">MATH</a>) dropped 21% to $0.7828.</li>
<li>eFFECTOR Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eftr#NASDAQ">EFTR</a>) dipped 20.7% to $0.50 after the company announced top-line results from its Phase 1b clinical trial of zotatifin for COVID-19 infection.</li>
<li>Unique Fabricating, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ufab#NASDAQ">UFAB</a>) fell 20% to $0.5115.</li>
<li>Donnelley Financial Solutions, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dfin#NYSE">DFIN</a>) declined 17.5% to $40.89 following downbeat Q4 results.</li>
<li>BioCryst Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bcrx#NASDAQ">BCRX</a>) fell 15.6% to $8.61 after the company reported worse-than-expected Q4 EPS results.</li>
<li>TH International Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thch#NASDAQ">THCH</a>) dropped 15% to $5.67. TH International recently entered into a transaction for the exclusive development of Popeyes in mainland China and Macau.</li>
<li>Dana Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dan#NYSE">DAN</a>) declined 14.7% to $16.07. Dana reported fourth-quarter FY22 sales growth of 12.4% year-on-year to $2.56 billion.</li>
<li>Lanvin Group Holdings Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lanv#NYSE">LANV</a>) fell 13.6% to $6.52.</li>
<li>Trinity Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/trn#NYSE">TRN</a>) dropped 13.4% to $24.56 following weak quarterly results.</li>
<li>Reata Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reta#NASDAQ">RETA</a>) fell 13.3% to $42.33.</li>
<li>SciSparc Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sprc#NASDAQ">SPRC</a>) fell 13% to $0.87. SciSparc shares gained around 10% on Friday after the company announced its MitoCareX Bio joint venture achieved its first milestone pursuant to the March 10, 2022 Founders and Investment Agreement.</li>
<li>Photronics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plab#NASDAQ">PLAB</a>) dropped 11.8% to $15.89 following Q1 results.</li>
<li>NexImmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nexi#NASDAQ">NEXI</a>) shares fell 11.4% to $0.5227. NexImmune recently announced data showing AIM ACT T cells enhance the response to bispecific T cell engager therapy at the 2023 Tandem Meetings: Transplantation &amp; Cellular Therapy Meetings of ASTCT and CIBMTR.</li>
<li>Snail, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snal#NASDAQ">SNAL</a>) fell 10.8% to $1.80.</li>
<li>JD.com, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jd#NASDAQ">JD</a>) fell 9.6% to $47.96 following a media report that the company is planning a $1.5 billion subsidy campaign to compete against rivals.</li>
<li>EnPro Industries, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/npo#NYSE">NPO</a>) dipped 9.5% to $108.30 following Q4 results.</li>
<li>Fastly, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsly#NYSE">FSLY</a>) fell 9.3% to $14.42. Citigroup maintained Fastly with a Sell and raised the price target from $7 to $8.</li>
<li>Sonic Automotive, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sah#NYSE">SAH</a>) dropped 9.1% to $54.56. JP Morgan downgraded Sonic Automotive from Overweight to Neutral and lowered the price target from $60 to $55.</li>
<li>Elanco Animal Health Incorporated (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/elan#NYSE">ELAN</a>) fell 8.6% to $12.00. Elanco Animal Health reported a Q4 FY22 revenue of $988 million.</li>
<li>Vinco Ventures, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bbig#NASDAQ">BBIG</a>) shares dropped 8.1% to $0.5295. VVIP Ventures recently entered into an Asset Purchase Agreement with magazine publisher a360 Media to acquire the National Enquirer, the National Examiner and Globe. VVIP Ventures is a joint venture between Vinco Ventures and ICON Publishing, LLC.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/02/30959765/top-5-tech-and-telecom-stocks-that-are-set-to-fly-this-month"> Top 5 Tech And Telecom Stocks That Are Set To Fly This Month </a>

Why CVRx Shares Are Trading Lower By 43%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>MicroAlgo Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mlgo#NASDAQ">MLGO</a>) shares jumped 74% to $2.90. MicroAlgo recently entered into securities purchase agreement for up to $3.2 million.</li>
<li>Akanda Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/akan#NASDAQ">AKAN</a>) gained 52% to $0.2980.</li>
<li>BuzzFeed, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bzfd#NASDAQ">BZFD</a>) rose 45.2% to $1.3804 after gaining over 5% on Wednesday. BuzzFeed, last month, reaffirmed its Q4 guidance.</li>
<li>Minerva Surgical, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/utrs#NASDAQ">UTRS</a>) shares gained 40.7% to $0.5345 after gaining 72% on Wednesday. Minerva Surgical recently announced a $30 million private placement of common stock led by Accelmed Partners.</li>
<li>Edible Garden AG Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/edbl#NASDAQ">EDBL</a>) surged 38% to $14.50. Edible Garden announced a 1-for-30 reverse stock split.</li>
<li>Qurate Retail, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qrteb#NASDAQ">QRTEB</a>) gained 37.7% to $6.70.</li>
<li>TRxADE HEALTH, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meds#NASDAQ">MEDS</a>) surged 30% to $0.5091.</li>
<li>Qualtrics International Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xm#NASDAQ">XM</a>) shares gained 28.9% to $14.45 after the company reported better-than-expected Q4 results and issued Q1 revenue guidance above estimates.</li>
<li>Scilex Holding Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sclx#NASDAQ">SCLX</a>) jumped 26.7% to $8.93.</li>
<li>Connexa Sports Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cnxa#NASDAQ">CNXA</a>) surged 25% to $0.3486.</li>
<li>Digihost Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dghi#NASDAQ">DGHI</a>) surged 20.2% to $1.7544.</li>
<li>PyroGenesis Canada Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pyr#NASDAQ">PYR</a>) gained 19.8% to $1.09.</li>
<li>American Rebel Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/areb#NASDAQ">AREB</a>) gained 18.6% to $0.2787 after jumping 17% on Wednesday.</li>
<li>Recruiter.com Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rcrt#NASDAQ">RCRT</a>) rose 17.4% to $0.5747.</li>
<li>Metalpha Technology Holding Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/math#NASDAQ">MATH</a>) gained 16.2% to $0.6163.</li>
<li>World Acceptance Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wrld#NASDAQ">WRLD</a>) surged 15.7% to $93.74 following Q3 results.</li>
<li>Xilio Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xlo#NASDAQ">XLO</a>) gained 15% to $4.5640.</li>
<li>Avaya Holdings Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/avya#NYSE">AVYA</a>) gained 12.4% to $0.4099.</li>
<li>Boot Barn Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/boot#NYSE">BOOT</a>) jumped 12.5% to $83.67 after the company reported better-than-expected Q3 sales results and issued Q4 and FY23 sales guidance above estimates.</li>
<li>NetScout Systems, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntct#NASDAQ">NTCT</a>) surged 11.4% to $35.26 following strong quarterly results.</li>
<li>Opendoor Technologies Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/open#NASDAQ">OPEN</a>) gained 11.1% to $1.79.</li>
<li>Tesla, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) rose 10.1% to $158.96 after the company reported better-than-expected results for its fourth quarter. Vehicle production totaled 439,701 units in the fourth quarter, while deliveries amounted to 405,278 electric vehicles.</li>
<li>DoubleVerify Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dv#NYSE">DV</a>) rose 9.9% to $27.94. DoubleVerify will replace Meridian Bioscience in the S&amp;P SmallCap 600 on Tuesday, Jan. 31.</li>
<li>Weibo Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/wb#NASDAQ">WB</a>) gained 9.8% to $24.11.</li>
<li>Seagate Technology Holdings plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/stx#NASDAQ">STX</a>) shares rose 9.5% to $68.13 after the company reported better-than-expected Q2 results.</li>
<li>DoubleVerify Holdings, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/dv#NYSE">DV</a>) jumped 9.3% to $27.80 after it was announced the company will join the S&amp;P SmallCap 600.</li>
<li>Nemaura Medical Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nmrd#NASDAQ">NMRD</a>) gained 9.1% to $2.88 after the company received first purchase order from U.S. health provider HealthFleet Inc.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcbp#NASDAQ">TCBP</a>) shares gained 8.7% to $4.38. HC Wainwright &amp; Co. initiated coverage on TC BioPharm with a Buy rating and announced a price target of $9.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>F-star Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/fstx#NASDAQ">FSTX</a>) shares declined 38.6% to $3.60. Hearing InvoX does not expect to get Committee on Foreign Investment in the U.S. approval for its proposed deal to acquire the company, according to Deal Reporter.</li>
<li>Panbela Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbla#NASDAQ">PBLA</a>) shares dipped 35.6% to $1.7450 after the company reported pricing of $15 million public offering at $2.75 per share.</li>
<li>Village Farms International, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vff#NASDAQ">VFF</a>) fell 34.4% to $0.9901 after the company announced a roughly $25 million registered direct offering.</li>
<li>Aridis Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ards#NASDAQ">ARDS</a>) fell 32.5% to $0.83 after the company announced top-line results from its AR-301-002 Phase 3 study, in which the primary endpoint was not met with statistical significance.</li>
<li>ThermoGenesis Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thmo#NASDAQ">THMO</a>) dropped 19.1% to $4.1099. ThermoGenesis recently regained compliance with Nasdaq minimum bid price requirement.</li>
<li>Altisource Portfolio Solutions S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asps#NASDAQ">ASPS</a>) fell 18.8% to $6.11.</li>
<li>Customers Bancorp, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cubi#NASDAQ">CUBI</a>) fell 18.2% to $26.05 after the company reported worse-than-expected Q4 EPS and sales results.</li>
<li>NeoVolta Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/neov#NASDAQ">NEOV</a>) fell 16.5% to $2.2550.</li>
<li>Paragon 28, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fna#NYSE">FNA</a>) dropped 16.3% to $16.81 after the company announced pricing of a public offering.</li>
<li>Inhibikase Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ikt#NASDAQ">IKT</a>) fell 16.3% to $0.72. Inhibikase Therapeutics announced $10 million concurrent registered direct offering and private placement priced at a premium to market under Nasdaq rules.</li>
<li>Covenant Logistics Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cvlg#NASDAQ">CVLG</a>) dropped 15.8% to $32.34 after the company reported worse-than-expected Q4 EPS results.</li>
<li>Lannett Company, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lci#NYSE">LCI</a>) dipped 15.8% to $0.5218. Lannett announced a 1-for -4 reverse stock split.</li>
<li>GeoVax Labs, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/govx#NASDAQ">GOVX</a>) fell 15.6% to $0.9368. GeoVax shares gained 59% on Wednesday after the company received a notice of allowance for its zika vaccine patent.</li>
<li>Plexus Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plxs#NASDAQ">PLXS</a>) dropped 15.3% to $95.88 after the company reported worse-than-expected Q1 sales results and issued Q2 EPS and revenue guidance below estimates.</li>
<li>Ocuphire Pharma, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ocup#NASDAQ">OCUP</a>) fell 13.2% to $3.2650 after the company reported topline results from ZETA-1 Phase 2 trial of oral APX3330 in diabetic retinopathy and plans for end-of-Phase 2 meeting with the FDA. HC Wainwright &amp; Co maintained Ocuphire Pharma with a Buy and lowered the price target from $26 to $20.</li>
<li>Bridger Aerospace Group Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/baer#NASDAQ">BAER</a>) dropped 12.8% to $19.24.</li>
<li>MarineMax, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/hzo#NYSE">HZO</a>) fell 10.6% to $30.99 after the company reported worse-than-expected Q1 adjusted EPS and sales results and lowered FY23 adjusted EPS guidance.</li>
<li>LendingClub Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/lc#NYSE">LC</a>) shares fell 10.4% to $9.26 following strong Q4 sales.</li>
<li>Magenta Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mgta#NASDAQ">MGTA</a>) shares fell 10.3% to $0.4439 after the company voluntarily paused the MGTA-117 Phase 1/2 dose-escalation clinical trial to investigate drug safety.</li>
<li>Intelligent Bio Solutions Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inbs#NASDAQ">INBS</a>) shares dropped 9.7% to $1.1201. Intelligent Bio Solutions recently announced it successfully completed the review of results from Milestone 7, a phase of its biosensor platform development.</li>
<li>Virtu Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/virt#NASDAQ">VIRT</a>) fell 9.4% to $18.57 as the company reported worse-than-expected Q4 adjusted EPS results.</li>
<li>Luokung Technology Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lkco#NASDAQ">LKCO</a>) fell 9.4% to $0.2075 after jumping around 24% on Wednesday.</li>
<li>The Sherwin-Williams Company (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/shw#NYSE">SHW</a>) dropped 7.6% to $228.24 after the company reported worse-than-expected Q4 revenue and issued soft FY23 guidance.</li>
<li>Diageo plc (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/deo#NYSE">DEO</a>) shares dropped 5.6% to $134.28 after the company reported first-half results.</li>
<li>International Business Machines Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ibm#NYSE">IBM</a>) fell 4.6% to $134.28. IBM reported better-than-expected sales for its fourth quarter on Wednesday. The company plans to reduce around 3,900 jobs that represent 1.5% of its global workforce, reported Bloomberg.</li>
<li>Wolfspeed, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/wolf#NYSE">WOLF</a>) fell 3.4% to $79.18 after the company reported worse-than-expected Q2 sales and issued soft guidance.</li>
</ul>
Also Check This Out <a href="https://www.benzinga.com/news/earnings/23/01/30589668/tesla-gets-price-target-bumps-by-analysts-after-strong-q4-results"> Tesla Gets Price Target Bumps By Analysts After Strong Q4 Results </a>

ARDS

AREB

ASPS

AVYA

BAER

BOOT

BZFD

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

CUBI

CVLG

DGHI

EDBL

FSTX

GOVX

Intelligent Bio Solutions Inc. - Common Stock

INBS

LKCO

MEDS

MGTA

MLGO

NEOV

NMRD

NTCT

OCUP

OPEN

PBLA

PLXS

QRTEB

RCRT

SCLX

TCBP

THMO

TSLA

UTRS

VIRT

WOLF

WRLD

Why Panbela Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

<h3>Gainers</h3>
<ul>
<li>World Acceptance (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WRLD#NASDAQ">WRLD</a>) stock moved upwards by 22.9% to $99.57 during Thursday's regular session. Trading volume for this security as of 12:30 EST is 134.7K, which is 154.7% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $623.0 million. As per the press release, Q3 earnings came out today. </li>
<li>Metalpha Technology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MATH#NASDAQ">MATH</a>) stock rose 14.35% to $0.58. The market value of their outstanding shares is at $15.5 million. </li>
<li>LendingTree (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TREE#NASDAQ">TREE</a>) shares rose 9.89% to $35.27. Trading volume for this security as of 12:30 EST is 183.5K, which is 66.2% of its average full-day volume over the last 100 days. The company's market cap stands at $451.0 million. </li>
<li>Mill City Ventures III (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCVT#NASDAQ">MCVT</a>) shares rose 9.65% to $2.51. The company's market cap stands at $15.5 million. </li>
<li>Value Line (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VALU#NASDAQ">VALU</a>) shares rose 8.93% to $54.35. The market value of their outstanding shares is at $513.6 million. </li>
<li>Pintec Technology Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PT#NASDAQ">PT</a>) stock increased by 8.57% to $0.38. The company's market cap stands at $3.2 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Customers Bancorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CUBI#NYSE">CUBI</a>) shares fell 19.1% to $25.75 during Thursday's regular session. Trading volume for Customers Bancorp's stock is 1.1 million as of 12:30 EST. This is 347.2% of its average full-day volume over the last 100 days. The company's market cap stands at $837.2 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>Alvarium Tiedemann Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALTI#NASDAQ">ALTI</a>) shares declined by 12.8% to $13.43. The current volume of 179.8K shares is 95.9% of Alvarium Tiedemann Hldgs's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $737.2 million. </li>
<li>LendingClub (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LC#NYSE">LC</a>) stock declined by 12.09% to $9.09. LendingClub's stock is trading at a volume of 4.6 million shares as of 12:30 EST. This is 270.1% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $955.2 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>Alerus Finl (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALRS#NASDAQ">ALRS</a>) stock fell 9.65% to $20.33. The current volume of 65.1K shares is 212.6% of Alerus Finl's average full-day volume over the last 100 days (last updated at 12:30 EST). The company's market cap stands at $406.3 million. As per the press release, Q4 earnings came out yesterday. </li>
<li>ConnectOne Bancorp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CNOB#NASDAQ">CNOB</a>) shares decreased by 9.64% to $22.07. The current volume of 189.1K shares is 142.7% of ConnectOne Bancorp's average full-day volume over the last 100 days (last updated at 12:30 EST). The market value of their outstanding shares is at $866.2 million. As per the news, the Q4 earnings report came out today. </li>
<li>Kearny Financial (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRNY#NASDAQ">KRNY</a>) stock decreased by 9.02% to $9.4. Kearny Financial's stock is trading at a volume of 134.7K shares as of 12:30 EST. This is 52.7% of its average full-day volume over the last 100 days. The company's market cap stands at $635.0 million. The company's, Q2 earnings came out today. 
See Also: <a href="http://www.benzinga.com/money/best-financial-services-stocks/" title="www.benzinga.com/money/best-financial-services-stocks/">www.benzinga.com/money/best-financial-services-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Comments

Metalpha Technology

Metalpha Technology (MATH) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga